Tashkent, Uzbekistan (UzDaily.com) -- Rosatom scientists presented the latest developments in the field of nuclear medicine at the Forum of Future Technologies, recently held in Moscow.

The forum participants were presented with equipment that allows them to grow new blood vessels, and bioimplants, and also showed new possibilities of radiopharmaceuticals and quantum computing in the field of medicine.

At the Rosatom exhibition stand, additive technologies relevant to the medical industry were presented. At the forum site, a prototype of a magnetoacoustic bioprinter, which is used to “grow” vessels, was demonstrated, as well as a bioreactor, where the vessel “learns” to work correctly. This device allows you to grow functional blood vessels of small diameter from the patient's biological material. A blood vessel grown from the patient’s own cells will not be rejected by the body, which is especially important in pediatric transplantology. 

Currently, Rosatom scientists have grown the equivalent of a blood vessel 2 cm long. By the end of the year, they plan to obtain equivalents up to 10 cm long. The experience of creating individual vessels will allow us to move on to the next step - complex branched systems, that is, growing entire organs, such as the thyroid gland , kidney, liver and others.

A device for “growing” blood vessels is not the only news announced on the sidelines of the Forum. Other unique developments include biosimilar implants with a special coating equivalent to bone tissue, which increases compatibility with patient tissue. Rosatom scientists were the first in the country to receive registration certificates for the developed special software, which allows them to create uniquely shaped implants in accordance with the patient’s CT and MRI data, and finished products.

The use of digital technologies reduces the time it takes to receive a finished implant from 60 to 7 days and speeds up the recovery of patients by 2-3 times.

The work of a quantum algorithm was also demonstrated, which allows identifying signs of pneumonia in X-ray images: the increase in the power of quantum computers will make it possible to detect diseases at the earliest stages.

At the exhibition within the framework of the Rosatom Future Technologies Forum, a new generation device intended for the treatment of oncological diseases was also shown for the first time - the Torus linear accelerator, as well as the Sanginox device, which unlimitedly synthesizes nitric oxide from the air and supplies it to the blood circuit when used for artificial blood circulation devices.

Forum guests were also introduced to the use of quantum technologies in solving modeling problems, which is important for the development of new materials and medicines.

“Rosatom enterprises are currently conducting developments in the interests of healthcare in such areas as additive technologies, radiopharmaceuticals and quantum computing. All the research we are doing in this area is aimed at significantly expanding the capabilities of doctors in providing care to patients. Thus, in the field of additive technologies, we are already creating implants from artificial biosimilar materials and are beginning to grow human organs from the patient’s own cells. In the field of nuclear medicine, we are developing innovative radiopharmaceuticals and will soon launch production of the entire range of radiopharmaceuticals that are used in global medical practice.

For this purpose, we are building the largest plant in Europe for the production of radiopharmaceutical products in Obninsk, Kaluga region. We are already working on the practical application of quantum computing in the medicine of the future, in particular, for detecting diseases at the earliest stages. Our developments are designed to take healthcare to a completely new level and achieve a completely different quality of life for people,” said Alexey Likhachev, Director General of Rosatom State Corporation.